CALR-mutated ET patients showed significantly higher levels of three molecules produced by T-cell subsets (IL-4, IL-9, IL-26), plus TGF-β2 and TGF-β3 (Figure 3a–e). The gene discussed is IL9; the disease is essential thrombocythemia.